US Stock MarketDetailed Quotes

Dyne Therapeutics (DYN)

Watchlist
  • 18.900
  • -0.770-3.91%
Close Apr 23 16:00 ET
3.12BMarket Cap-5.45P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dyne Therapeutics (DYN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
36.15%468.18M
19.59%116.13M
7.79%113.89M
60.91%115.79M
76.95%122.37M
42.01%343.89M
43.46%97.11M
69.67%105.66M
7.83%71.96M
52.11%69.16M
Selling and administrative expenses
11.80%69.85M
35.25%20.7M
29.66%16.67M
70.69%16.56M
-35.31%15.93M
98.98%62.48M
73.03%15.3M
83.12%12.86M
27.52%9.7M
210.52%24.62M
-General and administrative expense
11.80%69.85M
35.25%20.7M
29.66%16.67M
70.69%16.56M
-35.31%15.93M
98.98%62.48M
73.03%15.3M
83.12%12.86M
27.52%9.7M
210.52%24.62M
Research and development costs
41.55%398.33M
16.66%95.43M
4.76%97.22M
59.38%99.24M
139.00%106.45M
33.52%281.41M
39.02%81.81M
67.96%92.8M
5.30%62.26M
18.66%44.54M
Operating profit
-36.15%-468.18M
-19.59%-116.13M
-7.79%-113.89M
-60.91%-115.79M
-76.95%-122.37M
-42.01%-343.89M
-43.46%-97.11M
-69.67%-105.66M
-7.83%-71.96M
-52.11%-69.16M
Net non-operating interest income expense
-12.09%23.67M
-41.21%4.46M
-39.93%5.57M
-7.39%6.53M
136.51%7.1M
252.34%26.92M
333.58%7.59M
323.76%9.28M
219.53%7.05M
101.07%3M
Non-operating interest income
10.91%29.86M
0.86%7.66M
-8.62%8.48M
-6.06%6.63M
136.51%7.1M
252.34%26.92M
333.58%7.59M
323.76%9.28M
219.53%7.05M
101.07%3M
Non-operating interest expense
--6.19M
--3.19M
--2.9M
--94K
----
--0
--0
--0
--0
----
Other net income (expense)
-273.79%-1.7M
-1,011.54%-289K
137.60%279K
-731.77%-1.6M
-117.59%-89K
67.94%-454K
96.29%-26K
-488.89%-742K
48.53%-192K
334.26%506K
Other non- operating income (expenses)
-273.79%-1.7M
-1,011.54%-289K
137.60%279K
-731.77%-1.6M
-117.59%-89K
67.94%-454K
96.29%-26K
-488.89%-742K
48.53%-192K
334.26%506K
Income before tax
-40.58%-446.21M
-25.03%-111.96M
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.54%-317.42M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
Income tax
Net income
-40.58%-446.21M
-25.03%-111.96M
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.54%-317.42M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
Net income continuous Operations
-40.58%-446.21M
-25.03%-111.96M
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.54%-317.42M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
Minority interest income
Net income attributable to the parent company
-40.58%-446.21M
-25.03%-111.96M
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.54%-317.42M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-40.58%-446.21M
-25.03%-111.96M
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.54%-317.42M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
Basic earnings per share
-2.97%-3.47
13.64%-0.76
20.83%-0.76
-38.57%-0.97
-29.63%-1.05
14.68%-3.37
19.27%-0.88
3.03%-0.96
35.19%-0.7
-3.85%-0.81
Diluted earnings per share
-2.97%-3.47
13.64%-0.76
20.83%-0.76
-38.57%-0.97
-29.63%-1.05
14.68%-3.37
19.27%-0.88
3.03%-0.96
35.19%-0.7
-3.85%-0.81
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 36.15%468.18M19.59%116.13M7.79%113.89M60.91%115.79M76.95%122.37M42.01%343.89M43.46%97.11M69.67%105.66M7.83%71.96M52.11%69.16M
Selling and administrative expenses 11.80%69.85M35.25%20.7M29.66%16.67M70.69%16.56M-35.31%15.93M98.98%62.48M73.03%15.3M83.12%12.86M27.52%9.7M210.52%24.62M
-General and administrative expense 11.80%69.85M35.25%20.7M29.66%16.67M70.69%16.56M-35.31%15.93M98.98%62.48M73.03%15.3M83.12%12.86M27.52%9.7M210.52%24.62M
Research and development costs 41.55%398.33M16.66%95.43M4.76%97.22M59.38%99.24M139.00%106.45M33.52%281.41M39.02%81.81M67.96%92.8M5.30%62.26M18.66%44.54M
Operating profit -36.15%-468.18M-19.59%-116.13M-7.79%-113.89M-60.91%-115.79M-76.95%-122.37M-42.01%-343.89M-43.46%-97.11M-69.67%-105.66M-7.83%-71.96M-52.11%-69.16M
Net non-operating interest income expense -12.09%23.67M-41.21%4.46M-39.93%5.57M-7.39%6.53M136.51%7.1M252.34%26.92M333.58%7.59M323.76%9.28M219.53%7.05M101.07%3M
Non-operating interest income 10.91%29.86M0.86%7.66M-8.62%8.48M-6.06%6.63M136.51%7.1M252.34%26.92M333.58%7.59M323.76%9.28M219.53%7.05M101.07%3M
Non-operating interest expense --6.19M--3.19M--2.9M--94K------0--0--0--0----
Other net income (expense) -273.79%-1.7M-1,011.54%-289K137.60%279K-731.77%-1.6M-117.59%-89K67.94%-454K96.29%-26K-488.89%-742K48.53%-192K334.26%506K
Other non- operating income (expenses) -273.79%-1.7M-1,011.54%-289K137.60%279K-731.77%-1.6M-117.59%-89K67.94%-454K96.29%-26K-488.89%-742K48.53%-192K334.26%506K
Income before tax -40.58%-446.21M-25.03%-111.96M-11.24%-108.04M-70.28%-110.86M-75.72%-115.36M-34.54%-317.42M-34.37%-89.54M-61.31%-97.13M-0.31%-65.1M-48.57%-65.65M
Income tax
Net income -40.58%-446.21M-25.03%-111.96M-11.24%-108.04M-70.28%-110.86M-75.72%-115.36M-34.54%-317.42M-34.37%-89.54M-61.31%-97.13M-0.31%-65.1M-48.57%-65.65M
Net income continuous Operations -40.58%-446.21M-25.03%-111.96M-11.24%-108.04M-70.28%-110.86M-75.72%-115.36M-34.54%-317.42M-34.37%-89.54M-61.31%-97.13M-0.31%-65.1M-48.57%-65.65M
Minority interest income
Net income attributable to the parent company -40.58%-446.21M-25.03%-111.96M-11.24%-108.04M-70.28%-110.86M-75.72%-115.36M-34.54%-317.42M-34.37%-89.54M-61.31%-97.13M-0.31%-65.1M-48.57%-65.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -40.58%-446.21M-25.03%-111.96M-11.24%-108.04M-70.28%-110.86M-75.72%-115.36M-34.54%-317.42M-34.37%-89.54M-61.31%-97.13M-0.31%-65.1M-48.57%-65.65M
Basic earnings per share -2.97%-3.4713.64%-0.7620.83%-0.76-38.57%-0.97-29.63%-1.0514.68%-3.3719.27%-0.883.03%-0.9635.19%-0.7-3.85%-0.81
Diluted earnings per share -2.97%-3.4713.64%-0.7620.83%-0.76-38.57%-0.97-29.63%-1.0514.68%-3.3719.27%-0.883.03%-0.9635.19%-0.7-3.85%-0.81
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +18.81%
Sample Name
Sample Code
 +16.13%
Sample Name
Sample Code
 +12.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+11.25%
5
United Sts Brent Oil Fd Lp Unit
BNO
+8.06%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.80%
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +8.01%
4
Chagee Holdings
CHA
+5.92%
5
Taiwan Semiconductor
TSM
+5.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At midnight Beijing time on April 24, Iranian Parliament Speaker Kalibaf announced his withdrawal from the Iran-US negotiation delegation. M Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -